Stroke Detection: X-Ray Limitations And Alternatives

Ischemic stroke is a leading cause of long-term disability and death in adults. It occurs when there is a blockage in the blood supply to the brain, resulting in oxygen deprivation and cell death. The diagnosis and treatment of ischemic stroke have witnessed significant advancements, with neuroimaging playing a pivotal role.

Non-contrast CT scans are often the first-line imaging tool for stroke, helping to differentiate between ischemic and hemorrhagic strokes and assess the extent of hypoattenuation. CT angiography (CTA) and CT perfusion provide further insights into stroke pathology, aiding in the identification of vessel occlusions and perfusion deficits.

MRI techniques, such as diffusion-weighted imaging (DWI) and perfusion-weighted imaging (PWI), offer exceptional sensitivity and specificity in detecting early ischemic changes. These techniques can identify salvageable tissue, guiding treatment decisions and prognostication.

Advanced imaging technologies, including dual-energy CT, spectral CT, and photon-counting CT, enhance tissue differentiation and provide more accurate and rapid diagnoses. These advancements have revolutionized stroke management, enabling early intervention, accurate treatment decisions, and personalized care, ultimately improving patient outcomes.

The hyperdense vessel sign: a direct visualisation of the intravascular thrombus/embolus

The hyperdense vessel sign is a radiological sign observed on non-contrast CT brain scans, indicating focal hyperattenuation within an intracranial blood vessel. This sign is indicative of a fresh clot caused by vessel occlusion, primarily due to a thrombus or embolus. The CT attenuation value of non-occluded blood typically ranges from 40 to 43 Hounsfield units (HU), while the attenuation of an occlusive thrombus is significantly higher, ranging from 47 to 61 HU.

Hyperdense Vessel Sign in Intracranial Arteries

The hyperdense vessel sign is most commonly observed in the middle cerebral artery (MCA), where it appears as focal hyperattenuation in the M1 segment on non-contrast CT brain scans. This sign is one of the earliest visible radiological indicators of acute ischemic stroke and can be detected within 90 minutes of stroke onset. The hyperdense MCA sign has high specificity (95%) and moderate sensitivity (52%), making it a valuable diagnostic tool in time-critical acute stroke cases.

The hyperdense vessel sign can also be observed in other intracranial arteries, such as the internal carotid artery, anterior cerebral artery, posterior cerebral artery, basilar artery, and vertebral artery. However, these locations are less well-recognised and, therefore, less frequently reported. It is important for radiologists to be aware of these less common locations to improve the accuracy of stroke diagnosis and treatment.

Hyperdense Vessel Sign in Cerebral Venous Sinuses

Cerebral venous thrombosis (CVT) is a relatively uncommon but serious neurological disorder. A hyperdense thrombus in the occluded sinus is a classic finding of sinus thrombosis on non-contrast CT scans. However, this sign is only observed in about 20-25% of patients with CVT. The superior sagittal sinus is the most commonly affected sinus, followed by the transverse sinus, straight sinus, and cortical veins.

Potential Pitfalls in Diagnosis

It is important to be aware of potential pitfalls in the diagnosis of the hyperdense vessel sign. Intracranial vascular calcification may mimic this sign, but it can usually be distinguished due to its high CT attenuation, similar to that of bone. Additionally, hypoattenuation of surrounding brain parenchyma can lead to a false-positive hyperdense sign, particularly in readers with less experience. Beam-hardening artefacts from skull base bones can also cause adjacent vessels, especially vertebrobasilar arteries and cerebral venous sinuses, to appear hyperdense on non-contrast CT scans.

The hyperdense vessel sign observed on non-contrast CT brain scans is a reliable indicator of acute thrombus formation in intracranial vessels. This sign can be present in both acute ischemic stroke and CVT. Better awareness of this sign, especially in uncommon locations, is crucial for accurate and timely diagnosis and treatment. However, radiologists and clinicians need to be cautious of potential diagnostic pitfalls to avoid delays in patient care.

Loss of grey-white differentiation, and hypoattenuation of deep nuclei

Loss of grey-white differentiation and hypoattenuation of deep nuclei are early signs of ischemic stroke. They can be observed on a non-contrast CT scan within the first few hours of an ischemic stroke.

Loss of grey-white differentiation refers to the loss of the normal grey-white matter differentiation between the insular cortex and the subinsular white matter. Hypoattenuation of deep nuclei refers to the decreased density of the lentiform nucleus, which can be observed as early as 1 hour after occlusion.

CT perfusion: allows both the core of the infarct and the surrounding penumbra to be identified

CT perfusion is a technique used to identify the core of the infarct and the surrounding penumbra in ischemic stroke patients. It is a valuable tool that aids in treatment decisions and prognostication. The technique involves tracking a contrast medium as it flows into and out of the brain, generating four hemodynamic maps: cerebral blood flow (CBF), cerebral blood volume (CBV), mean transit time (MTT), and time to peak (TTP) or time to maximum (Tmax). These maps are then processed using deconvolution algorithms to calculate perfusion parameters.

The key to interpreting CT perfusion in ischemic stroke is understanding and identifying the infarct core and the ischemic penumbra. The infarct core is the part of the ischemic brain that has already infarcted or is destined to infarct, regardless of therapy. It is defined by prolonged MTT or Tmax, markedly decreased CBF, and reduced CBV. On the other hand, the ischemic penumbra surrounds the infarct core and has moderately reduced CBF but near-normal or increased CBV due to autoregulatory vasodilation.

CT perfusion has become an important adjunct to conventional CT imaging and CT angiography (CTA) in stroke centers. It enables the differentiation of salvageable ischemic brain tissue (penumbra) from the irrevocably damaged infarcted brain (infarct core). This information is crucial when assessing a patient's eligibility for reperfusion therapies, such as thrombolysis or clot retrieval.

The interpretation of CT perfusion involves the application of thresholds to the perfusion maps to quantify the volume of the infarct core and penumbra. A commonly used threshold for the infarct core is a relative CBF of less than 30% compared to normal brain tissue. The penumbra is then derived by subtracting the infarct core from the total perfusion deficit, which is the volume of brain tissue experiencing significant hypoperfusion.

The use of CT perfusion in acute ischemic stroke has several advantages. It improves diagnostic accuracy, aids in treatment target identification, and provides prognostic information. Additionally, CT perfusion can identify patients who may benefit from reperfusion beyond the conventional time window or those with unknown symptom onset times. However, there are also limitations and pitfalls associated with CT perfusion, such as overestimating the infarct core, especially in the early stages of a stroke, and challenges in visualizing small subcortical infarcts.

CT angiography: may identify thrombus within an intracranial vessel

CT angiography (CTA) is a non-invasive imaging technique that can be used to help diagnose and evaluate blood vessel diseases or related conditions. It involves injecting a contrast material into the patient's blood vessels and using a CT scanner to produce detailed images of both the blood vessels and surrounding tissues. This technique is particularly useful for examining the blood vessels in the brain and can help identify thrombus within intracranial vessels following an ischemic stroke.

CTA is often used in the rapid triage of patients with hyperacute stroke to determine the presence or absence of large vessel occlusion and guide treatment decisions. It has high sensitivity and specificity for detecting large vessel occlusion, which makes it valuable in the early stages of stroke management.

In the context of ischemic stroke, CTA can be used to identify thrombus within intracranial vessels. This information is crucial for determining the extent of the stroke and assessing the patient's eligibility for thrombolytic treatment or thrombectomy. The technique provides valuable insights into stroke pathology and aids in the differentiation between ischemic and hemorrhagic strokes.

CTA is often combined with other imaging techniques, such as perfusion imaging, to enhance the understanding of collateral circulation and identify salvageable tissue. This comprehensive approach enables physicians to make more informed decisions about reperfusion therapy and predict outcomes.

The use of CTA in ischemic stroke management has revolutionized patient care by providing rapid and detailed information about the patient's condition. It allows for more individualized treatment decisions and has led to improved stroke outcomes.

MRI: more time-consuming and less available than CT but has significantly higher sensitivity and specificity in the diagnosis of acute ischemic infarction in the first few hours after onset

Magnetic resonance imaging (MRI) is a more time-consuming and less available imaging technique than CT, but it has a significantly higher sensitivity and specificity in the diagnosis of acute ischemic infarction in the first few hours after onset. MRI is a more complicated and time-consuming examination than CT, but it has several advantages over CT. MRI is radiation-free and is considered safe for patients with allergies, high risk of nephrogenic systemic fibrosis, or longitudinal studies. MRI also has better detection of small lesions and "stroke mimics", and it can provide whole-brain coverage with a standard scanner.

However, CT is faster, more widely available, and more cost-effective than MRI. CT is also less restrictive and has fewer limitations in the CT environment.

Frequently asked questions